High Grade Serous Adenocarcinoma — Trials

High Grade Serous Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

45 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 30
Recruiting: 13
Ph III recruiting: 1
Growth YoY: —
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03610490	Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma	terminated	Phase 2	16	M.D. Anderson Cancer CenterOTHER	1	Apr 17, 2025	clinicaltrials
NCT05538624	A Study of Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary	terminated	Phase 1 / Phase 2	14	Avenge Bio, IncINDUSTRY	1	Apr 24, 2024